Exagen Statistics
NASDAQ: XGNHealth CareMedical SpecialitiesUSD
8.30+0.11 (+1.34%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Exagen by the numbers
Exagen has a market capitalization of $201.1 million based on 24.23M shares outstanding. With trailing EPS of $-0.82, Exagen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.5% above its 50-day average and 71.2% above its 200-day average.
Average daily trading volume is 332.40K shares, or about $2.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
XGN valuation vs. peer median
| Metric | XGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $201.07M | $89.82M | +124% |
| Avg. volume | 332.40K | 189.71K | +75% |
Peer median across 8 companies: BNR, TLSI, BDSX, KEQU, SERA, MDXH, ACH, ADVB.
Valuation
- Market cap
- $201.07M
- EPS (TTM)
- $-0.82
- Shares outstanding
- 24.23M
Price and trading
- Previous close
- 8.19
- Open
- 7.98
- Day range
- 7.89 – 8.36
- 52-week range
- 2.59 – 12.23
- 52-week change
- -24.27%
- Beta
- —
- Volume
- 234.91K
- Average volume
- 332.40K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 201.07M
- Forward Pe
- -17.66
- Eps
- -0.82
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 12.23
- Week52 Low
- 2.59
- Avg Volume
- 332.40K
- Shares Outstanding
- 24.23M
- Ma50
- 7.25
- Ma200
- 4.85
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -32.13%
- Pct From52w Low
- 220.46%